Performance of three generations of anti-hepatitis C virus enzyme- linked immunosorbent assays in donors and patients

Transfusion

Volumn 37, Issue 8, 1997, Pages 845-849

  Vrielink, H ^a   Reesink, H W ^a   Van Den Burg, P J M ^a   Zaaijer, H L ^a   Cuypers, H T M ^b   Lelie, P N ^b   Van Der Poel, C L ^a  

^a CENTRAL LABORATORY   (Netherlands)

^b Ctrl Lab Netherlands Red Cross B   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY;

ANTIBODY DETECTION; ARTICLE; BLOOD TRANSFUSION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C; HUMAN; IMMUNOBLOTTING; POLYMERASE CHAIN REACTION; SEROCONVERSION; VIRUS DETECTION;

EID: 0030863255     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1997.37897424409.x     Document Type: Article

References (28)

1. Kuo G, Choo QL, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989;244:362-4.
2. Van der Poel CL, Reesink HW, Schaasberg W, et al. Infectivity of blood seropositive for hepatitis C virus antibodies. Lancet 1990;350:558-60.
3. Contreras M, Barbara JA. Screening for hepatitis C virus antibody (letter). Lancet 1989;2:505.
4. Janot C, Couroucé AM, Maniez M. Antibodies to hepatitis C virus in French blood donors (letter). Lancet 1989;2:796-7.
5. Van der Poel CL. Hepatitis C virus; epidemiology, transmission and prevention. Curr Stud Hematol Blood Transfus 1994;61:137-63.
6. Van der Poel CL, Reesink HW, Lelie PN, et al. Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in The Netherlands. Lancet 1989;2:297-8.
7. Aach RD, Stevens CE, Hollinger FB, et al. Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first-and second-generation assays. N Engl J Med 1991;325:1325-9.
8. Bresters D, Cuypers HT, Reesink HW, et al. Enhanced sensitivity of a second generation ELISA for antibody to hepatitis C virus. Vox Sang 1992;62:213-7.
9. Kolho E. Specificity and sensitivity of first and second generation anti-HCV ELISA in a low prevalence population. Transfus Med 1992;2:239-42.
10. Kleinman S, Alter H, Busch M, et al. Increased detection of hepatitis C virus (HCV)-infected blood donors by a multiple-antigen HCV enzyme immunoassay. Transfusion 1992;32:805-13.
11. Van der Poel CL, Bresters D, Reesink HW, et al. Early anti-hepatitis C virus response with second-generation C200/C22 ELISA. Vox Sang 1992;62:208-12.
12. Leon P, Lopez JA, Domingo C, Echevarria JM. Evaluation of laboratory assays for screening antibody to hepatitis C virus. Transfusion 1993;33:268-70.
13. McHutchinson JG, Person JL, Govindarajan S, et al. Improved detection of hepatitis C virus antibodies in high-risk populations. Hepatology 1992;15:19-25.
14. Lelie PN, Cuypers HT, Reesink HW, et al. Patterns of serological markers in transfusion-transmitted hepatitis C virus infection using second-generation HCV assays. J Med Virol 1992;37:230-9.
15. Uyttendaele S, Claeys H, Mertens W, et al. Evaluation of third-generation screening and confirmatory assays for HCV antibodies. Vox Sang 1994;66:122-9.
16. Couroucé AM, Bouchardeau F, Girault A, Le Marrec N. Significance of NS3 and NS5 antigens in screening for HCV antibody (letter). Lancet 1994;343:853-4.
17. Vernelen K, Claeys H, Verhaert H, et al. Significance of NS3 and NS5 antigens in screening for HCV antibody (letter). Lancet 1994;343:853.
18. Lee SR, Wood CL, Lane MJ, et al. Increased detection of hepatitis C virus infection in commercial plasma donors by a third-generation screening assay. Transfusion 1995;35:845-9.
19. Couroucé AM, Le Marrec N, Girault A, et al. Anti-hepatitis C virus (anti-HCV) seroconversion in patients undergoing hemodialysis: comparison of second-and third-generation anti-HCV assays. Transfusion 1994;34:790-5.
20. Barrera JM, Francis B, Ercilla G, et al. Improved detection of anti-HCV in post-transfusion hepatitis by a third-generation ELISA. Vox Sang 1995;68:15-8.
21. Cuypers HT, Bresters D, Winkel IN, et al. Storage conditions of blood samples and primer selection affect the yield of cDNA polymerase chain reaction products of hepatitis C virus. J Clin Microbiol 1992;30:3220-4.
22. Vrielink H, van der Poel CL, Reesink HW, et al. Look-back study of infectivity of anti-HCV ELISA-positive blood components. Lancet 1995;345:95-6.
23. Vrielink H, van der Poel CL, Reesink HW, et al. Transmission of hepatitis C virus by anti-HCV-negative blood transfusion. Case report. Vox Sang 1995;68:55-6.
24. Van der Poel C, Cuypers H, Reesink H, et al. Risk factors in hepatitis C virus-infected blood donors. Transfusion 1991;31:777-9.
25. Vrielink H, Zaaijer HL, Reesink HW, et al. Comparison of two anti-hepatitis C virus enzyme-linked immunosorbent assays. Transfusion 1995;35:601-4.
26. Coffin E, Pirson Y, Cornu C, et al. Significance of NS3 and NS5 antigens in screening for HCV antibody (letter). Lancet 1994;343:854.
27. Dow BC, Follett EA, Jordan T, et al. Testing of blood donors for hepatitis C virus (letter). Lancet 1994;343:477-8.
28. Boyle RW, Dang E, Zhang M, Hosein B. Potency of NS-5 antigen of hepatitis C in identifying infectious blood donors (abstract). Transfusion 1993;33(Suppl):33S.